Ventilated patients (n = 59) | Weaned patients (n = 55) | p-value | |
---|---|---|---|
Age (years) | 60 (53–70) | 62 (53–62) | 0.43 |
Male gender | 35 (59) | 34 (62) | 0.78 |
Comorbidities | |||
Smoker | 18 (35) | 21 (47) | 0.23 |
Heavy drinker | 11 (19) | 16 (30) | 0.17 |
Obesity | 12 (20) | 10 (18) | 0.78 |
Congestive heart failure | 16 (27) | 12 (22) | 0.51 |
Peripheral vascular disease | 10 (17) | 9 (17) | 0.93 |
Cerebrovascular disease | 3 (5) | 6 (11) | 0.31 |
Diabetes | 13 (22) | 12 (22) | 0.68 |
Chronic kidney disease | 6 (10) | 6 (11) | 0.89 |
Chronic liver disease | 2 (3) | 6 (11) | 0.02 |
Malignancya | 7 (12) | 12 (22) | 0.15 |
COPD | 20 (34) | 23 (42) | 0.71 |
Restrictive lung disease | 5 (8) | 7 (13) | 0.92 |
Obstructive sleep apnea syndrome | 8 (14) | 5 (9) | 0.45 |
Neuromuscular disease | 11 (19) | 2 (4) | 0.02 |
Charlson Index of Comorbidity | 5 (4–7) | 6 (4–8) | 0.16 |
Main admission diagnosisb | |||
Postoperative | 6 (10) | 6 (11) | 0.92 |
Acute tetraplegia | 7 (12) | 8 (15) | 0.79 |
Trauma (excluding tetraplegia) | 3 (5) | 4 (7) | 0.71 |
Acute neurologic failure (excluding tetraplegia) | 10 (17) | 1 (2) | 0.06 |
Acute cardiac failure | 6 (10) | 4 (7) | 0.74 |
Septic shock | 1 (2) | 12 (22) | <0.001 |
Pneumonia (without septic shock) | 19 (32) | 37 (67) | <0.001 |
Exacerbation of COPD or other structural lung disease | 16 (27) | 10 (18) | 0.26 |
Acute on chronic hypercapnic failure at admissionc | 22 (37) | 12 (22) | 0.07 |
Vasopressor therapy during ICU stay | 27 (46) | 35 (63) | 0.48 |
Hemodialysis during ICU stay | 9 (15) | 10 (18) | 0.67 |
Time to tracheostomy (days) | 14 (8–20) | 16 (10–25) | 0.23 |
Time to ICU discharge (days) | 20 (10–39) | 29 (15–51) | 0.17 |
Time to weaning (days) | - | 18 (7–31) | - |